California’s Stem Cell Agency invested more than $42.1 million in translational-stage research

, , , , , ,

On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational research – from treating brain cancers and salivary gland conditions to advancing a therapy for a rare metabolic disease.

The goal of CIRM’s Translational program is to support promising stem cell-based or gene projects that accelerate completion of translational stage activities necessary for advancement to clinical study or broad end use. Those can include therapeutic candidates, diagnostic methods or devices and novel tools that address critical bottlenecks in research.

With $5.5 billion in funding and more than 150 active stem cell programs in our portfolio, CIRM is one of the world’s largest institutions dedicated to helping people by bringing the future of cellular medicine closer to reality.

Tags:


Source: California Institute for Regenerative Medicine
Credit:

Take your next career step with us.